Publication | Closed Access
Comparison of Serious Adverse Events Between the Original and a Generic Docetaxel in Breast Cancer Patients
14
Citations
10
References
2013
Year
Adverse events occurrence was similar between the 2 formulations. However, febrile neutropenia was more serious with generic docetaxel, despite increased G-CSF use. Results suggest that the studied generic formulation may be safe, but more caution during treatments might be warranted, especially concerning febrile neutropenia events.
| Year | Citations | |
|---|---|---|
Page 1
Page 1